Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
3
×
Tags
boston blog main
boston top stories
bristol-myers squibb
intercept pharmaceuticals
3
×
life sciences
national blog main
national top stories
new york blog main
new york top stories
san diego blog main
san diego top stories
3
×
san francisco blog main
san francisco top stories
biotech
boulder/denver blog main
boulder/denver top stories
celgene
clinical trials
detroit blog main
detroit top stories
indiana blog main
indiana top stories
liver
nash
national
nonalcoholic steatohepatitis
obeticholic acid
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
2019
4d molecular therapeutics
abbvie
acne
activism
What
disease
3
×
drug
liver
approved
bio
fatty
known
nash
race
roundup
advanced
alnylam’s
approval
bff
companies
conference
data
deals
devoted
digital
easl
epidemic
fda
form
frenzied
gene
growing
horizon
intercept
kicked
led
major
marketed
medicine
merck
new
news
nonalcoholic
steatohepatitis
strikes
Language
Current search:
disease
×
" intercept pharmaceuticals "
×
photo
×
" san diego top stories "
×
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug